Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 507

1.

Reply to T.M. Weis et al.

Bartlett NL, Wilson WH, Leonard JP.

J Clin Oncol. 2019 Sep 18:JCO1901617. doi: 10.1200/JCO.19.01617. [Epub ahead of print] No abstract available.

PMID:
31532721
2.

Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Young RM, Phelan JD, Wilson WH, Staudt LM.

Immunol Rev. 2019 Sep;291(1):190-213. doi: 10.1111/imr.12792. Review.

PMID:
31402495
3.

Reply to M. Skelin et al.

Wilson WH, Staudt L, Younes A.

J Clin Oncol. 2019 Oct 1;37(28):2584-2585. doi: 10.1200/JCO.19.01603. Epub 2019 Aug 7. No abstract available.

PMID:
31390273
4.

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttmann A, Casasnovas O, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, Wilson WH, Gaidano G, Rossi D, Bahlo J, Hallek M, Tibshirani R, Diehn M, Alizadeh AA.

Cell. 2019 Jul 25;178(3):699-713.e19. doi: 10.1016/j.cell.2019.06.011. Epub 2019 Jul 4.

PMID:
31280963
5.

Hybrid dosing of the cyclin-dependent kinase (CDK) inhibitor flavopiridol in relapsed/refractory mantle cell lymphoma and diffuse large B-cell lymphoma.

Miljkovic MD, Roschewski M, Dunleavy K, Wilson WH.

Leuk Lymphoma. 2019 Jun 17:1-4. doi: 10.1080/10428194.2019.1627540. [Epub ahead of print] No abstract available.

PMID:
31204529
6.

Liquid biopsy in non-Hodgkin's lymphoma.

Melani C, Wilson WH, Roschewski M.

Hematol Oncol. 2019 Jun;37 Suppl 1:70-74. doi: 10.1002/hon.2587. Review.

PMID:
31187522
7.

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.

Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP.

J Clin Oncol. 2019 Jul 20;37(21):1790-1799. doi: 10.1200/JCO.18.01994. Epub 2019 Apr 2.

PMID:
30939090
8.

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care - Authors' reply.

Wilson WH.

Lancet Haematol. 2019 Mar;6(3):e120. doi: 10.1016/S2352-3026(19)30020-1. No abstract available.

PMID:
30824037
9.

Reply to J. Wang et al.

Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas O, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA.

J Clin Oncol. 2019 Mar 20;37(9):755-757. doi: 10.1200/JCO.18.01907. Epub 2019 Feb 12. No abstract available.

PMID:
30753108
10.

Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas.

Roswarski J, Roschewski M, Melani C, Pittaluga S, Lucas A, Steinberg SM, Jaffe ES, Waldmann TA, Wilson WH.

Leuk Lymphoma. 2019 Aug;60(8):2062-2066. doi: 10.1080/10428194.2018.1562184. Epub 2019 Jan 10.

PMID:
30626252
11.

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.

Grande BM, Gerhard DS, Jiang A, Griner NB, Abramson JS, Alexander TB, Allen H, Ayers LW, Bethony JM, Bhatia K, Bowen J, Casper C, Choi JK, Culibrk L, Davidsen TM, Dyer MA, Gastier-Foster JM, Gesuwan P, Greiner TC, Gross TG, Hanf B, Harris NL, He Y, Irvin JD, Jaffe ES, Jones SJM, Kerchan P, Knoetze N, Leal FE, Lichtenberg TM, Ma Y, Martin JP, Martin MR, Mbulaiteye SM, Mullighan CG, Mungall AJ, Namirembe C, Novik K, Noy A, Ogwang MD, Omoding A, Orem J, Reynolds SJ, Rushton CK, Sandlund JT, Schmitz R, Taylor C, Wilson WH, Wright GW, Zhao EY, Marra MA, Morin RD, Staudt LM.

Blood. 2019 Mar 21;133(12):1313-1324. doi: 10.1182/blood-2018-09-871418. Epub 2019 Jan 7.

12.

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.

Dunleavy K, Fanale MA, Abramson JS, Noy A, Caimi PF, Pittaluga S, Parekh S, Lacasce A, Hayslip JW, Jagadeesh D, Nagpal S, Lechowicz MJ, Gaur R, Lucas A, Melani C, Roschewski M, Steinberg SM, Jaffe ES, Kahl B, Friedberg JW, Little RF, Bartlett NL, Wilson WH.

Lancet Haematol. 2018 Dec;5(12):e609-e617. doi: 10.1016/S2352-3026(18)30177-7.

PMID:
30501868
13.

Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA.

Melani C, Wilson WH, Roschewski M.

Best Pract Res Clin Haematol. 2018 Sep;31(3):285-292. doi: 10.1016/j.beha.2018.07.004. Epub 2018 Jul 3. Review.

PMID:
30213398
14.

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study.

Strati P, Fanale MA, Oki Y, Turturro F, Fayad LE, Bartlett NL, Gladstone DE, Kasamon YL, Portlock CS, Wilson WH, Goy A, Younes A, Lee HJ.

Haematologica. 2019 Feb;104(2):e65-e67. doi: 10.3324/haematol.2018.199844. Epub 2018 Sep 6. No abstract available.

15.

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA.

J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.

16.

Genetics of Diffuse Large B-Cell Lymphoma.

Wright GW, Wilson WH, Staudt LM.

N Engl J Med. 2018 Aug 2;379(5):493-494. doi: 10.1056/NEJMc1806191. No abstract available.

PMID:
30067933
17.

End-of-treatment and serial PET imaging has prognostic value and clinical utility in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R - Response to Adams et al.

Melani C, Roschewski M, Wilson WH.

Haematologica. 2018 Aug;103(8):e382. doi: 10.3324/haematol.2018.199547. No abstract available.

18.

ddPCR applied on archived Continuous Plankton Recorder samples reveals long-term occurrence of class 1 integrons and a sulphonamide resistance gene in marine plankton communities.

Di Cesare A, Petrin S, Fontaneto D, Losasso C, Eckert EM, Tassistro G, Borello A, Ricci A, Wilson WH, Pruzzo C, Vezzulli L.

Environ Microbiol Rep. 2018 Aug;10(4):458-464. doi: 10.1111/1758-2229.12665. Epub 2018 Aug 5.

PMID:
30022610
19.

A multiprotein supercomplex controlling oncogenic signalling in lymphoma.

Phelan JD, Young RM, Webster DE, Roulland S, Wright GW, Kasbekar M, Shaffer AL 3rd, Ceribelli M, Wang JQ, Schmitz R, Nakagawa M, Bachy E, Huang DW, Ji Y, Chen L, Yang Y, Zhao H, Yu X, Xu W, Palisoc MM, Valadez RR, Davies-Hill T, Wilson WH, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Rodriguez FJ, Estephan F, Holdhoff M, Kruhlak MJ, Hewitt SM, Thomas CJ, Pittaluga S, Oellerich T, Staudt LM.

Nature. 2018 Aug;560(7718):387-391. doi: 10.1038/s41586-018-0290-0. Epub 2018 Jun 20.

20.

End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making.

Melani C, Advani R, Roschewski M, Walters KM, Chen CC, Baratto L, Ahlman MA, Miljkovic MD, Steinberg SM, Lam J, Shovlin M, Dunleavy K, Pittaluga S, Jaffe ES, Wilson WH.

Haematologica. 2018 Aug;103(8):1337-1344. doi: 10.3324/haematol.2018.192492. Epub 2018 May 10.

21.

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, Hodson DJ, Xiao W, Yu X, Yang Y, Zhao H, Xu W, Liu X, Zhou B, Du W, Chan WC, Jaffe ES, Gascoyne RD, Connors JM, Campo E, Lopez-Guillermo A, Rosenwald A, Ott G, Delabie J, Rimsza LM, Tay Kuang Wei K, Zelenetz AD, Leonard JP, Bartlett NL, Tran B, Shetty J, Zhao Y, Soppet DR, Pittaluga S, Wilson WH, Staudt LM.

N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.

22.

What is the standard of care for primary mediastinal b-cell lymphoma; R-CHOP or DA-EPOCH-R?

Melani C, Wilson WH, Roschewski M.

Br J Haematol. 2019 Mar;184(5):836-838. doi: 10.1111/bjh.15185. Epub 2018 Mar 13. No abstract available.

PMID:
29532904
23.

P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.

Kalogeropulou AF, Zhao J, Bolliger MF, Memou A, Narasimha S, Molitor TP, Wilson WH, Rideout HJ, Nichols RJ.

Biochem J. 2018 Apr 9;475(7):1271-1293. doi: 10.1042/BCJ20170699.

PMID:
29519959
24.

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up.

Kreitman RJ, Tallman MS, Robak T, Coutre S, Wilson WH, Stetler-Stevenson M, FitzGerald DJ, Santiago L, Gao G, Lanasa MC, Pastan I.

Blood. 2018 May 24;131(21):2331-2334. doi: 10.1182/blood-2017-09-803072. Epub 2018 Feb 27.

25.

Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma.

Mailankody S, Kazandjian D, Korde N, Roschewski M, Manasanch E, Bhutani M, Tageja N, Kwok M, Zhang Y, Zingone A, Lamy L, Costello R, Morrison C, Hultcrantz M, Christofferson A, Washington M, Boateng M, Steinberg SM, Stetler-Stevenson M, Figg WD, Papaemmanuil E, Wilson WH, Keats JJ, Landgren O.

Blood Adv. 2017 Sep 29;1(22):1911-1918. doi: 10.1182/bloodadvances.2017005934. eCollection 2017 Oct 10.

26.

The Dynamics of Arrivals of Maine Migratory Breeding Birds: Results from a 24-Year Study.

Wilson WH.

Biology (Basel). 2017 Nov 12;6(4). pii: E38. doi: 10.3390/biology6040038.

27.

Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.

Roswarski J, Roschewski M, Lucas A, Melani C, Pittaluga S, Jaffe ES, Steinberg SM, Waldmann TA, Wilson WH.

Leuk Lymphoma. 2018 Jun;59(6):1466-1469. doi: 10.1080/10428194.2017.1387908. Epub 2017 Oct 16. No abstract available.

28.

Effect of statin on arginine metabolites in treated HIV-infection.

Dirajlal-Fargo S, El Kamari V, Sattar A, Alam K, Funderburg N, Labbato D, Pirro L, Longenecker CT, Wilson WH, McComsey GA.

Atherosclerosis. 2017 Nov;266:74-80. doi: 10.1016/j.atherosclerosis.2017.09.030. Epub 2017 Sep 28.

29.

Author Correction: Re-examination of the relationship between marine virus and microbial cell abundances.

Wigington CH, Sonderegger D, Brussaard CPD, Buchan A, Finke JF, Fuhrman JA, Lennon JT, Middelboe M, Suttle CA, Stock C, Wilson WH, Wommack KE, Wilhelm SW, Weitz JS.

Nat Microbiol. 2017 Nov;2(11):1571. doi: 10.1038/s41564-017-0042-1.

PMID:
28974689
30.

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

Melani C, Major A, Schowinsky J, Roschewski M, Pittaluga S, Jaffe ES, Pack SD, Abdullaev Z, Ahlman MA, Kwak JJ, Morgan R, Rabinovitch R, Pan Z, Haverkos BM, Gutman JA, Pollyea DA, Smith CA, Wilson WH, Kamdar M.

N Engl J Med. 2017 Jul 6;377(1):89-91. doi: 10.1056/NEJMc1704767. No abstract available.

31.

MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.

Lai C, Roschewski M, Melani C, Pittaluga S, Shovlin M, Steinberg SM, Dunleavy K, Pack S, Jaffe ES, Wilson WH.

Leuk Lymphoma. 2018 Feb;59(2):505-508. doi: 10.1080/10428194.2017.1339882. Epub 2017 Jun 22. No abstract available.

32.

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.

Lionakis MS, Dunleavy K, Roschewski M, Widemann BC, Butman JA, Schmitz R, Yang Y, Cole DE, Melani C, Higham CS, Desai JV, Ceribelli M, Chen L, Thomas CJ, Little RF, Gea-Banacloche J, Bhaumik S, Stetler-Stevenson M, Pittaluga S, Jaffe ES, Heiss J, Lucas N, Steinberg SM, Staudt LM, Wilson WH.

Cancer Cell. 2017 Jun 12;31(6):833-843.e5. doi: 10.1016/j.ccell.2017.04.012. Epub 2017 May 25.

33.

Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier.

Navarro A, Clot G, Martínez-Trillos A, Pinyol M, Jares P, González-Farré B, Martínez D, Trim N, Fernández V, Villamor N, Colomer D, Costa D, Salaverria I, Martín-Garcia D, Erber W, López C, Jayne S, Siebert R, Dyer MJS, Wiestner A, Wilson WH, Aymerich M, López-Guillermo A, Sánchez À, Campo E, Matutes E, Beà S.

Haematologica. 2017 Sep;102(9):e360-e363. doi: 10.3324/haematol.2016.160374. Epub 2017 May 18. No abstract available.

34.

Genomic exploration of individual giant ocean viruses.

Wilson WH, Gilg IC, Moniruzzaman M, Field EK, Koren S, LeCleir GR, Martínez Martínez J, Poulton NJ, Swan BK, Stepanauskas R, Wilhelm SW.

ISME J. 2017 Aug;11(8):1736-1745. doi: 10.1038/ismej.2017.61. Epub 2017 May 12.

35.

Exploratory analysis of Symbiodinium transcriptomes reveals potential latent infection by large dsDNA viruses.

Lawrence SA, Floge SA, Davy JE, Davy SK, Wilson WH.

Environ Microbiol. 2017 Oct;19(10):3909-3919. doi: 10.1111/1462-2920.13782. Epub 2017 May 29.

PMID:
28464391
36.

Marine Prasinoviruses and Their Tiny Plankton Hosts: A Review.

Weynberg KD, Allen MJ, Wilson WH.

Viruses. 2017 Mar 15;9(3). pii: E43. doi: 10.3390/v9030043. Review.

37.

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.

Nowakowski GS, Blum KA, Kahl BS, Friedberg JW, Baizer L, Little RF, Maloney DG, Sehn LH, Williams ME, Wilson WH, Leonard JP, Smith SM.

J Natl Cancer Inst. 2016 Dec 16;108(12). pii: djw257. doi: 10.1093/jnci/djw257. Print 2016 Dec. Review.

38.

Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV.

Dirajlal-Fargo S, Alam K, Sattar A, Kulkarni M, Funderburg N, Wilson WH, McComsey GA.

AIDS. 2017 Feb 20;31(4):533-537. doi: 10.1097/QAD.0000000000001363.

39.

Drivers of interannual variability in virioplankton abundance at the coastal western Antarctic peninsula and the potential effects of climate change.

Evans C, Brandsma J, Pond DW, Venables HJ, Meredith MP, Witte HJ, Stammerjohn S, Wilson WH, Clarke A, Brussaard CP.

Environ Microbiol. 2017 Feb;19(2):740-755. doi: 10.1111/1462-2920.13627.

PMID:
27902869
40.

Update on Burkitt Lymphoma.

Dunleavy K, Little RF, Wilson WH.

Hematol Oncol Clin North Am. 2016 Dec;30(6):1333-1343. doi: 10.1016/j.hoc.2016.07.009. Review.

PMID:
27888884
41.

How Biobanks Are Assessing and Measuring Their Financial Sustainability.

Brown T, Kelly DD, Vercauteren SM, Wilson WH, Werner A.

Biopreserv Biobank. 2017 Feb;15(1):65-71. doi: 10.1089/bio.2016.0086. Epub 2016 Nov 21.

PMID:
27869475
42.

Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.

Queirós AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, Raineri E, Russiñol N, Castellano G, Beà S, Navarro A, Kulis M, Verdaguer-Dot N, Jares P, Enjuanes A, Calasanz MJ, Bergmann A, Vater I, Salaverría I, van de Werken HJG, Wilson WH, Datta A, Flicek P, Royo R, Martens J, Giné E, Lopez-Guillermo A, Stunnenberg HG, Klapper W, Pott C, Heath S, Gut IG, Siebert R, Campo E, Martín-Subero JI.

Cancer Cell. 2016 Nov 14;30(5):806-821. doi: 10.1016/j.ccell.2016.09.014.

43.

Re-examination of the relationship between marine virus and microbial cell abundances.

Wigington CH, Sonderegger D, Brussaard CP, Buchan A, Finke JF, Fuhrman JA, Lennon JT, Middelboe M, Suttle CA, Stock C, Wilson WH, Wommack KE, Wilhelm SW, Weitz JS.

Nat Microbiol. 2016 Jan 25;1:15024. doi: 10.1038/nmicrobiol.2015.24. Erratum in: Nat Microbiol. 2017 Nov;2(11):1571.

PMID:
27572161
44.

Commentary: Experimental evidence for compositional syntax in bird calls.

Phillips S, Wilson WH.

Front Psychol. 2016 Aug 3;7:1171. doi: 10.3389/fpsyg.2016.01171. eCollection 2016. No abstract available.

45.

Systematicity and a Categorical Theory of Cognitive Architecture: Universal Construction in Context.

Phillips S, Wilson WH.

Front Psychol. 2016 Jul 29;7:1139. doi: 10.3389/fpsyg.2016.01139. eCollection 2016.

46.

Second-Order Systematicity of Associative Learning: A Paradox for Classical Compositionality and a Coalgebraic Resolution.

Phillips S, Wilson WH.

PLoS One. 2016 Aug 9;11(8):e0160619. doi: 10.1371/journal.pone.0160619. eCollection 2016.

47.

Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.

Gharwan H, Lai C, Grant C, Dunleavy K, Steinberg SM, Shovlin M, Fojo T, Wilson WH.

Leuk Lymphoma. 2016 Jul;57(7):1616-24. doi: 10.3109/10428194.2015.1118476. Epub 2016 May 17.

PMID:
27183887
48.

Role of the tumor microenvironment in mature B-cell lymphoid malignancies.

Fowler NH, Cheah CY, Gascoyne RD, Gribben J, Neelapu SS, Ghia P, Bollard C, Ansell S, Curran M, Wilson WH, O'Brien S, Grant C, Little R, Zenz T, Nastoupil LJ, Dunleavy K.

Haematologica. 2016 May;101(5):531-40. doi: 10.3324/haematol.2015.139493. Review.

49.

Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.

Saba NS, Liu D, Herman SE, Underbayev C, Tian X, Behrend D, Weniger MA, Skarzynski M, Gyamfi J, Fontan L, Melnick A, Grant C, Roschewski M, Navarro A, Beà S, Pittaluga S, Dunleavy K, Wilson WH, Wiestner A.

Blood. 2016 Jul 7;128(1):82-92. doi: 10.1182/blood-2015-11-681460. Epub 2016 Apr 28.

50.

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

Roschewski M, Staudt LM, Wilson WH.

Blood. 2016 Jun 23;127(25):3127-32. doi: 10.1182/blood-2016-03-635219. Epub 2016 Apr 14. Review.

Supplemental Content

Loading ...
Support Center